| Citation: |
JIN Hui, SHI Wenjun, JIANG Weihua, ZHANG Ying. Effect of nursing-led auricular acupressure on chemotherapy-induced peripheral neuropathy of patients with breast cancer[J]. Journal of Clinical Medicine in Practice, 2024, 28(16): 125-127, 135. DOI: 10.7619/jcmp.20240738
|
To observe the effect of nursing-led auricular acupressure therapy in improving the symptoms of peripheral neuropathy in breast cancer patients with chemotherapy of paclitaxel.
A total of 86 patients were randomly divided into study group and control group, with 43 cases in each group. The study group was treated with traditional western medicine and auricular acupressure, while the control group was treated with traditional western medicine alone. The clinical efficacy and scores of peripheral neuropathy symptoms were compared between the two groups.
After treatment, the scores of limb numbness, limb pain, fatigue and tendon reflex in both groups were significantly lower than those before treatment, and the scores of the above symptoms in the study group were significantly lower than those in the control group (P < 0.05).The total effective rate of the study group was 88.4% (38/43), which was significantly higher than 74.4% (32/43) in the control group (P < 0.05).
The nursing-led auricular acupressure therapy combined with mecobalamin can improve the symptoms of peripheral neurotoxicity in breast cancer patients treated with paclitaxel, with the advantages of non-invasiveness, simplicity, safety, flexibility, cost-effectiveness, and good compliance.
| [1] |
SERETNY M, CURRIE G L, SENA E S, et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis[J]. Pain, 2014, 155(12): 2461-2470.
|
| [2] |
Sugimoto M, Komatsu H, Hayashida T. Association of chemotherapy-induced peripheral neuropathy, physical activity and health-related quality of life among breast cancer patients[J]. Journal of Japanese Society of Cancer Nursing, 2021, 35: 29-35.
|
| [3] |
DEMIRCI U. Management of patients with factor Ⅶ deficiency in surgery: a single center experience[J]. Erciyes Med J, 2021, 44(2): 222-228.
|
| [4] |
FRADKIN M, BATASH R, ELMALEH S, et al. Management of peripheral neuropathy induced by chemotherapy[J]. Curr Med Chem, 2019, 26(25): 4698-4708.
|
| [5] |
SELVY M, PEREIRA B, KERCKHOVE N, et al. Prevention, diagnosis and management of chemotherapy-induced peripheral neuropathy: a cross-sectional study of French oncologists' professional practices[J]. Support Care Cancer, 2021, 29(7): 4033-4043.
|
| [6] |
SAMUELS N, BEN-ARYE E. Integrative approaches to chemotherapy-induced peripheral neuropathy[J]. Curr Oncol Rep, 2020, 22(3): 23.
|
| [7] |
SCHUTZMEIER P, KUTZORA S, MITTERMEIER I, et al. Non-pharmacological interventions for pollen-induced allergic symptoms: Systematic literature review[J]. Pediatr Allergy Immunol, 2022, 33(1): e13690. http://pubmed.ncbi.nlm.nih.gov/34717016/
|
| [8] |
KIEFFER J M, POSTMA T J, VAN DE POLL-FRANSE L, et al. Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)[J]. Qual Life Res, 2017, 26(11): 2999-3010.
|
| [9] |
BÉRUBÉ-MERCIER P, TAPP D, CIMON M ō, et al. Evaluation of the psychometric properties of patient-reported and clinician-reported outcome measures of chemotherapy-induced peripheral neuropathy: a COSMIN systematic review protocol[J]. BMJ Open, 2022, 12(4): e057950.
|
| [10] |
ARGYRIOU A A, KOLTZENBURG M, POLYCHRONOPOULOS P, et al. Peripheral nerve damage associated with administration of taxanes in patients with cancer[J]. Crit Rev Oncol Hematol, 2008, 66(3): 218-228.
|
| [11] |
徐革, 连娜琪, 于洋, 等. 化疗药所致周围神经病变发生机制和治疗的研究进展[J]. 医学综述, 2020, 26(18): 3601-3605, 3611. doi: 10.3969/j.issn.1006-2084.2020.18.012
|
| [12] |
TAWFIK A A, HAMZA S A, ADLY N N, et al. Pattern of cognitive impairment among community-dwelling elderly in Egypt and its relation to socioeconomic status[J]. J Egypt Public Health Assoc, 2024, 99(1): 4.
|
| [13] |
YEH C H, LUKKAHATAI N, CAMPBELL C, et al. Preliminary effectiveness of auricular point acupressure on chemotherapy-induced neuropathy: part 1 self-reported outcomes[J]. Pain Manag Nurs, 2019, 20(6): 614-622.
|
| [14] |
Mai Q, Li X, Yang D, et al. Effects of acupressure on cancer-related pain management: a systematic review and meta-analysis of randomized controlled trials[J]. Eur J Integr Med, 2022, 51: 102120.
|
| [15] |
王小玲, 钱巧云, 徐丽霞. 耳穴埋籽配合心理护理对乳腺癌化疗致恶心及呕吐的干预[J]. 实用临床医药杂志, 2017, (12): 177-178. doi: 10.7619/jcmp.201712058
|
| [16] |
LI T, PARK S B, BATTAGLINI E, et al. Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations for future use[J]. Qual Life Res, 2022, 31(11): 3091-3107.
|
| [17] |
武琼华, 孙淑琴, 王静, 等. 中药穴位贴敷外治法干预糖尿病周围神经病变的临床疗效[J]. 实用临床医药杂志, 2023, 27(20): 137-141. doi: 10.7619/jcmp.20231985
|
| [18] |
周肖, 丁彩艳, 刘慧, 等. 化疗致外周神经毒性患者适应性研究进展[J]. 实用临床医药杂志, 2022, 26(8): 137-142, 148. doi: 10.7619/jcmp.20214940
|
| 1. |
曹贻元. 舒芬太尼对瑞芬太尼麻醉后早期疼痛的预防效果. 中国卫生标准管理. 2022(15): 109-113 .
| |
| 2. |
张志强. 舒芬太尼预防瑞芬太尼麻醉后早期疼痛的临床研究. 首都食品与医药. 2019(04): 36-37 .
| |
| 3. |
李玉琢. 舒芬太尼联合右美托咪定的麻醉和术后镇痛效果. 河南医学研究. 2019(09): 1634-1635 .
| |
| 4. |
郑孝振，韩箫笛，宋俊杰，毛姗姗，白明松，洪道先. 鞘内注射舒芬太尼对慢性神经痛大鼠脊髓背角NMDA受体表达的影响. 中国合理用药探索. 2019(05): 1-3+7 .
| |
| 5. |
买宇，张春华，鲍杰，孙坤. 羟考酮与舒芬太尼术后镇痛对结肠癌患者免疫功能的影响比较. 中国药业. 2019(21): 47-49 .
| |
| 6. |
赵立，梁永新. 瑞芬太尼联合丙泊酚应用于食道异物取出术的麻醉效果分析. 医学信息. 2018(11): 93-95 .
| |
| 7. |
刘毅，赖敏. 舒芬太尼对雷米芬太尼麻醉后缓解早期疼痛的临床疗效评价. 抗感染药学. 2018(12): 2139-2141 .
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: